Is Peg-interferon plus ribavirin a cost-effective therapy, and if so, what is the most efficient way to use this therapy in naive patients with chronic hepatitis C?
JOURNAL OF HEPATOLOGY（2002）
关键词
cost effectiveness
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要